Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Option exercise EVP & CHIEF INNOVATION OFFICER acquired 30,646 shares (option exercise)
  6. 8-K Event Shareholder vote results
  7. 4 Open-market buy Director bought 613,497 shares at $5.41 ($3,319,019)
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 4 Open-market buy Director bought 8,000 shares at $5.78 ($46,240)
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. ARS Other Annual Report to Security Holders
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. 4 Open-market buy Director bought 8,000 shares at $6.20 ($49,600)
  17. S-3ASR Offering Registration Statement
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 2 of 27 · 524 filings